Why Is MEI Pharma Stock Soaring On Friday?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 18 2025
0mins
Should l Buy ?
Source: Benzinga
MEI Pharma's Investment and Stock Performance: MEI Pharma, Inc. is experiencing a surge in stock price, trading at $5.92 after a 31.54% increase, following a private investment deal that raised approximately $100 million through the sale of 29.2 million shares at $3.42 each.
Adoption of Litecoin as Treasury Asset: The company has become the first publicly traded entity to adopt Litecoin as a treasury reserve asset, appointing Charlie Lee to its board and engaging GSR for digital asset management, marking a significant step in its long-term strategic plan.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
